Toward Engineered Cells as Transformational and Broadly Available Medicines for the Treatment of Cancer

Jan 14, 2018 by in ONCOLOGY Comments Off on Toward Engineered Cells as Transformational and Broadly Available Medicines for the Treatment of Cancer

Antigen Antigen class Phase Comment Alpha fetoprotein (αFP) Differentiation Preclinical  Carcinoembryonic antigen (CEA) Differentiation Ph1 Terminated—poor accrual Glycoprotein 100 (Gp100) Differentiation Ph2  Hepatitis B virus (HBV) antigen Viral antigen Ph1 …

read more

Oncolytic Viruses: T-VEC and Others

Jan 14, 2018 by in ONCOLOGY Comments Off on Oncolytic Viruses: T-VEC and Others

Fig. 24.1 Mechanism of action of oncolytic viruses: selective replication in cancer cells, tumor lysis, release of virus, and spread within cancer tissue (Reproduced from Kirn D et al. (2001)…

read more

Cancer Vaccines for HPV Malignancies

Jan 14, 2018 by in ONCOLOGY Comments Off on Cancer Vaccines for HPV Malignancies

Fig. 15.1 Global incidence of pathogen-induced human malignancies in 2012 [96] Fig. 15.2 Number of new HPV-associated cancers in 2009 [3] Exposure to HPV occurs with sexual debut and is…

read more

Immunotherapy for Prostate Cancer: An Evolving Landscape

Jan 14, 2018 by in ONCOLOGY Comments Off on Immunotherapy for Prostate Cancer: An Evolving Landscape

Fig. 35.1 Disease progression of prostate cancer from initial diagnosis until death. Local therapies such as surgery and radiation can control initial disease, and hormone-naïve tumors see clinical benefit from…

read more

IDO/TDO Inhibition in Cancer

Jan 14, 2018 by in ONCOLOGY Comments Off on IDO/TDO Inhibition in Cancer

Fig. 17.1 Sites of IDO/TDO expression and action in cancer. Expression of IDO1, IDO2, and TDO documented in various cells in the tumor microenvironment (including metastatic sites) and in tumor-draining…

read more

Synergy Between Radiotherapy and Immunotherapy

Jan 14, 2018 by in ONCOLOGY Comments Off on Synergy Between Radiotherapy and Immunotherapy

Fig. 30.1 Margins used in radiation treatment. GTV gross tumor volume, CTV clinical target volume, PTV planning target volume One rapidly evolving area is in the treatment of patients with…

read more
Get Clinical Tree app for offline access